Latest news
RenovoRx Announces First Commercial Clinical Use of RenovoCath® in Sarcoma Patient Treatment, Marking Expansion of Targeted Drug-Delivery Device to Other Solid Tumors - Investing News NetworkInvesting News Network · Thu, 06 Aug 2026 22:13:08 GMTRenovoRx Announces First Commercial Clinical Use Of RenovoCath In Sarcoma Patient Treatment - marketscreener.commarketscreener.com · Thu, 06 Aug 2026 12:30:00 GMT